SleepMed Incorporated is a pioneering healthcare company established in 1999, with a mission to elevate the under-served sleep disorders market. As the largest private sleep diagnostics and therapy provider in the United States, it conducts over 200,000 tests annually, collaborating with about 15,000 independent physicians and hospital network partners. The company's DigiTrace technology, initially developed at Beth Israel Medical Center in Boston, serves as a revolutionary tool in the industry, with a track record of being the gold standard for ambulatory EEG testing in the US.
In 2013, SleepMed successfully merged with Watermark Medical, a prominent name in home sleep testing (HST), renowned for pioneering cloud-based HST for Obstructive Sleep Apnea. This union has positioned SleepMed as a formidable force to combat the widespread sleep issues impacting millions of Americans, leveraging the latest sleep diagnostic and therapy technologies and integrating cloud computing into their operations.
With the slogan "Better Sleep. Better Health.", SleepMed is committed to providing patients with a streamlined and transparent process from testing to therapy, recognizing the pivotal role of sleep in overall well-being. While the company's last investment details are not disclosed, its innovative approach and established market presence make it an attractive potential investment opportunity for venture capitalists operating in the healthcare sector.